Edition:
United Kingdom

Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

9.35USD
16 Feb 2018
Change (% chg)

$0.55 (+6.25%)
Prev Close
$8.80
Open
$8.85
Day's High
$9.38
Day's Low
$8.85
Volume
51,863
Avg. Vol
51,454
52-wk High
$9.40
52-wk Low
$3.70

Chart for

About

Codexis, Inc. is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company's CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers... (more)

Overall

Beta: -1.55
Market Cap(Mil.): $331.02
Shares Outstanding(Mil.): 48.32
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Telemark Asset Management LLC reports 6.72 pct passive stake in Codexis ‍​as of Nov 10

* Telemark Asset Management LLC reports 6.72 percent passive stake in Codexis Inc ‍​as of November 10 - SEC Filing Source text: [http://bit.ly/2AYhX8Y] Further company coverage:

20 Nov 2017

BRIEF-Codexis Q3 non-gaap loss per share $0.17

* Codexis reports financial results for the third quarter of 2017

09 Nov 2017

BRIEF-Codexis Inc, Nestlé Health Science enter strategic collaboration​

* Codexis Inc - ‍co, Nestlé Health Science enter strategic collaboration​

12 Oct 2017

Competitors

  Price Chg
Kao Corp (4452.T) ¥7,889 -108.00
Royal Dutch Shell Plc (RDSa.AS) €25.78 --
Royal Dutch Shell Plc (RDSb.L) 2,283.00 --
BP plc (BP.L) 474.05 --
BP plc (BP_p.L) 161.00 0.00
BP plc (BP_pb.L) 169.00 0.00
Sasol Limited (SOLJ.J) 40,500.00 --
Sasol Limited (SOLBE1J.J) 36,000.00 --
BASF SE (BASFn.DE) €86.25 --
Pfizer Inc. (PFE.N) $36.26 +0.55

Earnings vs. Estimates